To answer this question from Robert Small of Stannard, we take stock of not one, not two, but three pharmaceuticals currently in development.

This episode features reporting from Sue Halpern, who coincidentally answered Robert’s question for The New Yorker in August: Why It Took So Long to Develop a Vaccine for Lyme Disease.

More recommended reading:

• The Lyme Vaccine That Got Away (from The New Republic’s podcast The Politics of Everything)
• vaccine-history-lymerix-hesitancy-ticks.html">Where’s My Lyme Vaccine? (from Slate)
• Finally, a Shot to Prevent Lyme Disease Could Be on Its Way (from Outside — heads up, this one’s behind a paywall)

As always, our journalism is better when you’re a part of it:

• Ask a question about Vermont
• Sign up for the BLS newsletter
• Say hi on Twitter, Instagram and reddit @bravestatevt
• Drop us an email: hello@bravelittlestate.org
• Make a gift to support people-powered journalism
• Tell your friends about the show!

This episode was reported and produced by Angela Evancie, with help from Josh Crane. Mix and sound design by Josh Crane, and digital production by Myra Flynn. Ty Gibbons composed our theme music; other music by Blue Dot Sessions and Myra Flynn.

Brave Little State is a production of Vermont Public Radio.